Home > Research > Publications & Outputs > Development and validation of a predictive mode...
View graph of relations

Development and validation of a predictive model for endocervical curettage in patients referred for colposcopy: A multicenter retrospective diagnostic study in China

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • Peng Xue
  • Bingrui Wei
  • Samuel Seery
  • Qing Li
  • Zichen Ye
  • Yu Jiang
  • Youlin Qiao
<mark>Journal publication date</mark>30/08/2022
<mark>Journal</mark>Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Issue number4
Number of pages11
Pages (from-to)395-405
Publication StatusPublished
<mark>Original language</mark>English


This study aimed to develop a nomogram that can predict occult high-grade squamous intraepithelial lesions or worse (HSIL+) and determine the need for endocervical curettage (ECC) in patients referred for colposcopy. This retrospective multicenter study included 4,149 patients who were referred to any one of six tertiary hospitals in China for colposcopy between January 2020 and November 2021 because of abnormal screening results. ECC data were extracted from the medical records. Univariate and multivariate logistic regression analyses were performed to identify factors that could predict HSIL+ on ECC. Patients were randomly assigned to a training set or to an internal validation set for performance and comparability testing. The model was externally validated and tested in patients from two additional hospitals. The nomogram was assessed in terms of discrimination and calibration and subjected to decision curve analysis. HSIL+ was found on ECC in 38.8% (n=388) of cases. Our predictive nomogram included age group, cytology, human papillomavirus (HPV) status, visibility of the cervix and colposcopic impression. The nomogram had good overall discrimination, which was internally validated [area under the receiver-operator characteristic (AUC), 0.839; 95% confidence interval (95% CI), 0.773-0.904]. In terms of external validation, the AUC was 0.843 (95% CI, 0.773-0.912) for the consecutive sample and 0.843 (95% CI, 0.783-0.902) for the comparative sample. Calibration analysis suggested good consistency between predicted and observed probabilities. Decision curve analysis suggested this nomogram would be clinically useful with almost the entire range of threshold probabilities. This internally and externally validated nomogram can be easily applied and incorporates multiple clinically relevant variables that can be used to identify patients with occult HSIL+ who need ECC.